|
Volumn 98, Issue 5, 2001, Pages 1627-1629
|
Strategies for management of cytomegalovirus (CMV) infection after allogeneic bone marrow transplantation: The "doubling of baseline CMV pp65 antigenemia" and the "cidofovir as rescue treatment" approaches [2] (multiple letters)
a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CIDOFOVIR;
FOSCARNET;
GANCICLOVIR;
ALLOGENIC BONE MARROW TRANSPLANTATION;
CHEMOPROPHYLAXIS;
CYTOMEGALOVIRUS;
CYTOMEGALOVIRUS INFECTION;
DRUG EFFICACY;
HUMAN;
LETTER;
PRIORITY JOURNAL;
PROGNOSIS;
VIREMIA;
VIRUS TRANSMISSION;
|
EID: 0035469863
PISSN: 00064971
EISSN: None
Source Type: Journal
DOI: 10.1182/blood.V98.5.1627 Document Type: Letter |
Times cited : (2)
|
References (0)
|